Immediate and long-term clinical and angiographic results from Wiktor stent treatment for true bifurcation narrowings

Citation
A. Anzuini et al., Immediate and long-term clinical and angiographic results from Wiktor stent treatment for true bifurcation narrowings, AM J CARD, 88(11), 2001, pp. 1246-1250
Citations number
13
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF CARDIOLOGY
ISSN journal
00029149 → ACNP
Volume
88
Issue
11
Year of publication
2001
Pages
1246 - 1250
Database
ISI
SICI code
0002-9149(200112)88:11<1246:IALCAA>2.0.ZU;2-E
Abstract
From January 1996 to December 1998, 90 consecutive patients with true bifur cation lesions underwent percutaneous coronary angioplasty with Wiktor sten t implantation in our centers. In I group (group I, n = 45), a simple appro ach (main vessel stenting and balloon angioplasty of the side branch) was p ursued. In the other group (group II, n = 45), both the main vessel and the side branch were stented ("T" technique). There was no significant differe nce in clinical and angiographic characteristics between the 2 groups. Angi ographic and procedural successes were 100% and 95.6%, respectively, in bot h groups. Angiographic results for the side branch were better in group If than in group I. in-hospital and long-term (12 month) major cardiac events were similar in the 2 groups. Target lesion revascularization was 15.5% in group I and 35.5% in group II (p = 0.12). In the main vessel, restenosis ra te was 12.5% in group I and 25% in group II (p = 0.15). In the side branch, restenosis rate was 37.5% in group II and 12.5% in group I (p = <0.05; odd s ratio 2.42; 95% confidence interval 1.05 to 6.26). Event-free probability at 12 months was 61% in group If and 80% in group I (p = 0.10). When deali ng with true bifurcation lesions, a simple strategy is associated with a lo wer risk of restenosis in the side branch. In contrast, a complex approach does not appear to give any benefit in terms of early or long-term outcome or restenosis rate. (C) 2001 by Excerpta Medica, Inc.